The resulting NPs had dual-targeting, CD44 (HA), and mitochondrial-targeting properties (TPP), which was confirmed by the results showing that cancer cells favorably uptake these NPs via CD44 receptor-mediated endocytosis and are largely accumulated in mitochondria. Here, CD44 is linked to cancer.